Sharing Experiences on company success with Samm Anderegg
Samm Anderegg is Chief Executive Officer at DocStation, a software platform that connects pharmacists and health plans to operate value-based care models.
Welcome to the University of Iowa Research Park, where collaborative opportunities in technology abound.
We offer corporations locating at the Park convenient, sustained access to the extensive, relevant research resources of The University of Iowa.
Here, growing enterprises have access to a state-of-the art business incubator, world-class research facilities and a dynamic faculty of scientists, physicians and engineers at one of the world’s leading public research universities.
News & Announcements
Viewpoint Awarded $2M NCI Phase II SBIR to conduct Phase 1 clinical trial at Mayo Clinic
Viewpoint Molecular Targeting, Inc., a University of Iowa start-up pharmaceutical company that has developed novel therapy and companion diagnostics for cancer, announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant valued at $2 million from the National Cancer Institute (NCI) The award will support preclinical development and a Phase 1 clinical imaging trial of it’s VMT01 companion diagnostic in advance of therapeutic trials.
Viewpoint Awarded $300K NIH Phase I SBIR
Viewpoint Molecular Targeting, Inc. has been awarded a $300,000 Small Business Innovation Research (SBIR) Phase I Grant by the National Institutes of Health.
Events
There are currently no results to display.